Showing results (711-720 of 781) with videos related to
Sort By:
Pageof 79
Arthritis & Rheumatology (Hoboken, N.J.)|January 12, 2026
In synergy with interferon-gamma, interleukin-17 activates vascular stromal cells towards a pro-inflammatory profile in giant cell arteritisHélène Greigert, André Ramon, Claudie Cladiere, et al.JCI Insight|March 24, 2022
The synovial and blood monocyte DNA methylomes mirror prognosis, evolution, and treatment in early arthritisCarlos de la Calle-Fabregat, Javier Rodríguez-Ubreva, Laura Ciudad, et al.Leukemia|May 10, 2000
BIOMED-1 concerted action report: flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL)A Porwit-MacDonald, E Björklund, P Lucio, et al.Haematologica|October 3, 2009
TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemiaOlivier Kosmider, Véronique Gelsi-Boyer, Marion Ciudad, et al.Blood|February 15, 2003
Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias: early immunophenotypic evaluation has high clinical valueMaría-Belén Vidriales, José J Pérez, Maria Consuelo López-Berges, et al.International Journal of Molecular Sciences|December 11, 2022
Detection of SARS-CoV-2 Virus by Triplex Enhanced Nucleic Acid Detection Assay (TENADA)Anna Aviñó, Carlos Cuestas-Ayllón, Manuel Gutiérrez-Capitán, et al.Heart (British Cardiac Society)|October 5, 2019
Contemporary epidemiology and outcomes in recurrent infective endocarditisAfonso B Freitas-Ferraz, Gabriela Tirado-Conte, Isidre Vilacosta, et al.British Journal of Haematology|September 22, 2021
Prognostic heterogeneity of adult B-cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3-PBX1 treated with measurable residual disease-oriented protocolsJordi Ribera, Isabel Granada, Mireia Morgades, et al.Journal of Autoimmunity|May 17, 2021
Mucosal-associated invariant T cells in Giant Cell ArteritisThibault Ghesquière, Marion Ciudad, André Ramon, et al.Blood|November 6, 2009
Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation settingLuis I Sánchez-Abarca, Silvia Gutierrez-Cosio, Carlos Santamaría, et al.Pageof 79